The World Cancer Immunotherapy Conference 2012 covers topics such as:
- FDA guidance for cancer vaccine developers and regulatory challenges
- Cancer vaccine clinical trial design
- Optimal disease settings for cancer vaccine intervention
- Biomarkers as an aid to clinical development of cancer vaccines
- Cancer vaccines in combination therapies
The World Cancer Immunotherapy Conference 2012 brings together C-Level executives and leading scientists from around the world.
